Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
American Journal of Clinical Dermatology
Published in: American Journal of Clinical Dermatology 5/2014

01-10-2014 | Review Article

Neutrophilic Dermatoses: An Update

Authors: Afsaneh Alavi, Dusan Sajic, Felipe B. Cerci, Danny Ghazarian, Misha Rosenbach, Joseph Jorizzo

Published in: American Journal of Clinical Dermatology | Issue 5/2014

Login to get access

Abstract

Neutrophilic dermatoses constitute a heterogeneous group of dermatologic diseases, which are unified by the predominance of neutrophils within the inflammatory infiltrate on histopathology. The aims of this review were to provide an update on the clinical and histologic presentation of the main neutrophilic dermatoses and to develop a guide for clinical practice. A structured literature search of PubMed, Medline, and Embase was performed, using the key words “neutrophilic disorders”, “cutaneous small vessel vasculitis”, “Sweet’s syndrome”, “bowel associated dermatosis arthritis syndrome”, “Behcet’s”, “palisaded neutrophilic and granulomatous dermatosis”, “rheumatoid neutrophilic dermatitis”, and “pyoderma gangrenosum”. Related articles were screened for key terms and were included if appropriate. This group contains a wide spectrum of unique disorders, each with its own histologic and clinical subtleties, making specific diagnosis of a given entity within the group diagnostically challenging. The fact that overlapping forms of neutrophilic dermatoses, which share features of multiple neutrophilic dermatoses, are not uncommon makes the diagnoses more challenging.
Literature
1.
Jorizzo JL, Solomon AR, Zanolli MD, Leshin B. Neutrophilic vascular reactions. J Am Acad Dermatol. 1988;19(6):983–1005.PubMedCrossRef
2.
3.
4.
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11.PubMedCrossRef
5.
Russell JP, Gibson LE. Primary cutaneous small vessel vasculitis: approach to diagnosis and treatment. Int J Dermatol. 2006;45(1):3–13.PubMedCrossRef
6.
Sais G, Vidaller A, Jucgla A, Servitje O, Condom E, Peyri J. Prognostic factors in leukocytoclastic vasculitis: a clinicopathologic study of 160 patients. Arch Dermatol. 1998;134(3):309–15.PubMedCrossRef
7.
Ekenstam E, Callen JP. Cutaneous leukocytoclastic vasculitis: clinical and laboratory features of 82 patients seen in private practice. Arch Dermatol. 1984;120(4):484–9.CrossRef
8.
Caucanas M, Heylen A, Rolland F, Muller G, Olemans C, Sass U, et al. Associated pyoderma gangrenosum, erythema elevatum diutinum, and Sweet’s syndrome: the concept of neutrophilic disease. Int J Dermatol. 2013;52(10):1185–8.PubMed
9.
Swerlick RA, Lawley TJ. Cutaneous vasculitis: its relationship to systemic disease. Med Clin N Am. 1989;73(5):1221–35.PubMed
10.
Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol. 2005;27(6):504–28.PubMedCrossRef
11.
Peuvrel L, Quereux G, Brocard A, Saint-Jean M, Freour E, Josselin N, et al. Atypical cutaneous vasculitis under lapatinib. Eur J Dermatol. 2013;23(4):540–1.PubMed
12.
Novoa RA, Honda K, Koon HB, Gerstenblith MR. Vasculitis and panniculitis associated with vemurafenib. J Am Acad Dermatol. 2012;67(6):e271–2.PubMedCrossRef
13.
Podjasek JO, Wetter DA, Pittelkow MR, Wada DA. Cutaneous small-vessel vasculitis associated with solid organ malignancies: the Mayo Clinic experience, 1996–2009. J Am Acad Dermatol. 2012;66(2):e55–65.PubMedCrossRef
14.
Ingraffea A, Donohue K, Wilkel C, Falanga V. Cutaneous vasculitis in two patients taking an herbal supplement containing black cohosh. J Am Acad Dermatol. 2007;56(5 Suppl):S124–6.PubMedCrossRef
15.
Podjasek JO, Wetter DA, Pittelkow MR, Wada DA. Henoch-Schonlein purpura associated with solid-organ malignancies: three case reports and a literature review. Acta Derm Venereol. 2012;92(4):388–92.PubMedCrossRef
16.
Lever WF, Schaumburg-Lever S. Histopathology of the skin. Philadelphia: JB Lippincott; 1990.
17.
Zax RH, Hodge SJ, Callen JP. Cutaneous leukocytoclastic vasculitis: serial histopathologic evaluation demonstrates the dynamic nature of the infiltrate. Arch Dermatol. 1990;126(1):69–72.PubMedCrossRef
18.
Bahrami S, Malone JC, Webb KG, Callen JP. Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis. Arch Dermatol. 2006;142(2):155–61.PubMedCrossRef
19.
Haeberle MT, Adams WB, Callen JP. Treatment of severe cutaneous small-vessel vasculitis with mycophenolate mofetil. Arch Dermatol. 2012;148(8):887–8.PubMedCrossRef
20.
21.
Rochet NM, Chavan RN, Cappel MA, Wada DA, Gibson LE. Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients. J Am Acad Dermatol. 2013;69(4):557–64.PubMedCrossRef
22.
Anzalone CL, Cohen PR. Acute febrile neutrophilic dermatosis (Sweet’s syndrome). Curr Opin Hematol. 2013;20(1):26–35.PubMedCrossRef
23.
Paydas S. Sweet’s syndrome: a revisit for hematologists and oncologists. Crit Rev Oncol/Hematol. 2013;86(1):85–95.CrossRef
24.
Cohen PR. Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol. 2009;10(5):301–12.PubMedCrossRef
25.
Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet’s syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol. 2013;45(2):202–10.PubMedCrossRef
26.
Walker DC, Cohen PR. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol. 1996;34(5 Pt 2):918–23.PubMedCrossRef
27.
Bonamigo RR, Razera F, Olm GS. Neutrophilic dermatoses: part I. An Bras Dermatol. 2011;86(1):11–25 (quiz 26–7).PubMedCrossRef
28.
Parsapour K, Reep MD, Gohar K, Shah V, Church A, Shwayder TA. Familial Sweet’s syndrome in 2 brothers, both seen in the first 2 weeks of life. J Am Acad Dermatol. 2003;49(1):132–8.PubMedCrossRef
29.
Razera F, Olm GS, Bonamigo RR. Neutrophilic dermatoses: part II. An Bras Dermatol. 2011;86(2):195–209 (quiz 210–1).PubMedCrossRef
30.
Vanourny J, Swick BL. Sweet syndrome with systemic inflammatory response syndrome. Arch Dermatol. 2012;148:969–70.
31.
32.
Requena L, Kutzner H, Palmedo G, Pascual M, Fernandez-Herrera J, Fraga J, et al. Histiocytoid Sweet syndrome: a dermal infiltration of immature neutrophilic granulocytes. Arch Dermatol. 2005;141(7):834–42.PubMedCrossRef
33.
Chavan RN, Cappel MA, Ketterling RP, Wada DA, Rochet NM, Knudson R, et al. Histiocytoid Sweet syndrome may indicate leukemia cutis: a novel application of fluorescence in situ hybridization. J Am Acad Dermatol. 2014;70(6):1021–7.PubMedCrossRef
34.
Raza S, Kirkland RS, Patel AA, Shortridge JR, Freter C. Insight into Sweet’s syndrome and associated-malignancy: a review of the current literature. Int J Oncol. 2013;42(5):1516–22.
35.
Halawai A, Abiad F, Abbas O. Bariatric surgery and its effects on the skin and skin diseases. Obes Surg. 2013;23:408–13.
36.
Dicken CH, Seehafer JR. Bowel bypass syndrome. Arch Dermatol. 1979;115:837–9.
37.
Tu J, Chan JJ, Yu LL. Bowel bypass syndrome/bowel-associated dermatosis arthritis syndrome post laparoscopic gastric bypass surgery. Aust J Dermatol. 2011;52:e5–7.
38.
Jorizzo JL, Apisarnthanarax P, Subrt P, Hebert AA, Henry JC, Raimer SS, et al. Bowel-bypass syndrome without bowel bypass. Bowel-associated dermatosis-arthritis syndrome. Arch Int Med. 1983;143:457–61.
39.
Slater GH, Kerlin P, Georghiou PR, Fielding GA. Bowel-associated dermatosis-arthritis syndrome after biliopancreatic diversion. Obes Surg. 2004;14:133–5.
40.
Prpic-Massari L, Kastelan M, Brajac I, Cabrijan L, Zamolo G, Massari D. Bowel-associated dermatosis–arthritis syndrome in a patient with appendicitis. Med Sci Monit. 2007;13(8):CS97–100.PubMed
41.
Mendoza-Pinto C, Garcia-Carrasco M, Jimenez-Hernandez M, Jimenez Hernandez C, Riebeling-Navarro C, Nava Zavala A, et al. Etiopathogenesis of Behcet’s disease. Autoimmun Rev. 2010;9:241–5.
42.
Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, et al. Behcet’s disease: from East to West. Clin Rheumatol. 2010;29:823–33.
43.
Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, et al. Behcet’s disease in Iran: analysis of 6500 cases. Int J Rheum Dis. 2010;13(4):367–73.PubMedCrossRef
44.
Hatemi G, Seyahi E, Fresko I, Hamuryudan V. Behcet’s syndrome: a critical digest of the recent literature. Clin Exp Rheumatol. 2012;30(3 Suppl 72):S80–9.
45.
Zhou ZY, Chen SL, Shen N, Lu Y. Cytokines and Behcet’s disease. Autoimmun Rev. 2012;11:699–704.
46.
Emmi G, Silvestri E, Ciucciarelli L, Squatrito D, Emmi L. Anti-IL1 blocking agents in drug-resistant Behcet’s syndrome: our little case series. Clin Exp Rheum. Epub 2014 Apr 7.
47.
Urbaniak P, Hasler P, Kretzschmar S. Refractory neuro-Behcet treated by tocilizumab: a case report. Clin Exp Rheumatol. 2012;30(3 Suppl 72):S73–5.PubMed
48.
49.
Wilmoth GJ, Perniciaro C. Cutaneous extravascular necrotizing granuloma (Winkelmann granuloma): confirmation of the association with systemic disease. J Am Acad Dermatol. 1996;34(5 Pt 1):753–9.PubMedCrossRef
50.
Kim SK, Park CK, Park YW, Jun JB, Yoo DH, Bae SC. Palisaded neutrophilic granulomatous dermatitis presenting as an unusual skin manifestation in a patient with Behcet’s disease. Scand J Rheumatol. 2005;34(4):324–7.PubMedCrossRef
51.
Hantash BM, Chiang D, Kohler S, Fiorentino D. Palisaded neutrophilic and granulomatous dermatitis associated with limited systemic sclerosis. J Am Acad Dermatol. 2008;58(4):661–4.PubMedCrossRef
52.
Kreuter A, Rose C, Zillikens D, Altmeyer P. Bullous rheumatoid neutrophilic dermatosis. J Am Acad Dermatol. 2005;52(5):916–8.PubMedCrossRef
53.
Fujio Y, Funakoshi T, Nakayama K, Amagai M, Ohyama M. Rheumatoid neutrophilic dermatosis with tense blister formation: a case report and review of the literature. Australas J Dermatol. 2012;.;55((1):):e12–4.
54.
Sangueza OP, Caudell MD, Mengesha YM, Davis LS, Barnes CJ, Griffin JE, et al. Palisaded neutrophilic granulomatous dermatitis in rheumatoid arthritis. J Am Acad Dermatol. 2002;47(2):251–7.PubMedCrossRef
55.
Biswas A, Chittari K, van Gey Pittius D, Stephens M, Tan BB. Palisaded neutrophilic and granulomatous dermatitis in a child with type I diabetes mellitus and coeliac disease. Br J Dermatol. 2008;159(2):488–9.PubMedCrossRef
56.
Germanas JP, Mehrabi D, Carder KR. Palisaded neutrophilic granulomatous dermatitis in a 12-year-old girl with systemic lupus erythematosus. J Am Acad Dermatol. 2006;55(2 Suppl):S60–2.PubMedCrossRef
57.
Hunt RD, Hartman RD, Molho-Pessach V, Votava HJ, Schaffer JV. Palisaded neutrophilic and granulomatous dermatitis in an adolescent girl with perinuclear antineutrophil cytoplasmic antibody-positive pauci-immune glomerulonephritis and arthritis. J Am Acad Dermatol. 2012;67(4):e164–6.PubMedCrossRef
58.
Chu P, Connolly MK, LeBoit PE. The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease. Arch Dermatol. 1994;130(10):1278–83.PubMedCrossRef
59.
Ergun T, Inanc N, Tuney D, Kotiloglu EK, Seckin D, Tetik C, et al. Skin manifestations of rheumatoid arthritis: a study of 215 Turkish patients. Int J Dermatol. 2008;47(9):894–902.PubMedCrossRef
60.
Bremner R, Simpson E, White CR, Morrison L, Deodhar A. Palisaded neutrophilic and granulomatous dermatitis: an unusual cutaneous manifestation of immune-mediated disorders. Semin Arthritis Rheum. 2004;34(3):610–6.PubMedCrossRef
61.
Edgerton CC, Oglesby RJ, Bray D. Rheumatoid neutrophilic dermatitis. J Clin Rheum. 2006;12(5):266–7.CrossRef
62.
Yamamoto T, Ohkubo H, Nishioka K. Skin manifestations associated with rheumatoid arthritis. J Dermatol. 1995;22(5):324–9.PubMed
63.
Bevin AA, Steger J, Mannino S. Rheumatoid neutrophilic dermatitis. Cutis. 2006;78(2):133–6.PubMed
64.
Sanchez JL, Cruz A. Rheumatoid neutrophilic dermatitis. J Am Acad Dermatol. 1990;22(5 Pt 2):922–5.PubMedCrossRef
65.
Hirota TK, Keough GC, David-Bajar K, McCollough ML. Rheumatoid neutrophilic dermatitis. Cutis. 1997;60(4):203–5.PubMed
66.
Setterfield JF, Shirlaw PJ, Challacombe SJ, Black MM. Pyoderma gangrenosum associated with severe oropharyngeal involvement and IgA paraproteinaemia. Br J Dermatol. 2001;144(2):393–6.PubMedCrossRef
67.
Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol. 2012;13(3):191–211.PubMedCrossRef
68.
Perry HO, Winkelmann RK. Bullous pyoderma gangrenosum and leukemia. Arch Dermatol. 1972;106(6):901–5.PubMedCrossRef
69.
O’Loughlin S, Perry HO. A diffuse pustular eruption associated with ulcerative colitis. Arch Dermatol. 1978;114(7):1061–4.PubMedCrossRef
70.
Su WP, Davis MD, Weenig RH, Powell FC, Perry HO. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol. 2004;43(11):790–800.PubMedCrossRef
71.
Brooklyn TN, Dunnill MG, Shetty A, Bowden JJ, Williams JD, Griffiths CE, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut. 2006;55(4):505–9.PubMedCrossRefPubMedCentral
72.
Dinarello CA. A clinical perspective of IL-1beta as the gatekeeper of inflammation. Eur J Immunol. 2011;41(5):1203–17.PubMedCrossRef
73.
Hadi A, Lebwohl M. Clinical features of pyoderma gangrenosum and current diagnostic trends. J Am Acad Dermatol. 2011;64(5):950–4.PubMedCrossRef
74.
Weenig RH, Davis MD, Dahl PR, Su WP. Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med. 2002;347(18):1412–8.PubMedCrossRef
Metadata
Title
Neutrophilic Dermatoses: An Update
Authors
Afsaneh Alavi
Dusan Sajic
Felipe B. Cerci
Danny Ghazarian
Misha Rosenbach
Joseph Jorizzo
Publication date
01-10-2014
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 5/2014
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-014-0092-6

Other articles of this Issue 5/2014

American Journal of Clinical Dermatology 5/2014 Go to the issue

Evidence-Based Review

Imiquimod in the Treatment of Cutaneous Warts: An Evidence-Based Review

Original Research Article

Relationship Between Helicobacter pylori Infection and Vitiligo: A Prospective Study

Review Article

Dermatological Toxicity Associated with Targeted Therapies in Cancer: Optimal Management

Review Article

Treatment of Pediculosis Capitis: A Critical Appraisal of the Current Literature

Review Article

Neonatal Junctional Epidermolysis Bullosa: Treatment Conundrums and Ethical Decision Making

Leading Article

Biologic Therapy with or Without Topical Treatment in Psoriasis: What Does the Current Evidence Say?